Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1)

Kuniko Sunami; Yoichi Naito; Eriko Aimono; Toraji Amano; Daisuke Ennishi; Hidenori Kage; Masashi Kanai; Keigo Komine; Takafumi Koyama; Takahiro Maeda; Sachi Morita; Daisuke Sakai; Shinji Kohsaka; Katsuya Tsuchihara; Takayuki Yoshino

doi:10.1007/s10147-021-01897-w

Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1)

Kuniko Sunami
, Yoichi Naito
, Eriko Aimono
, Toraji Amano
, Daisuke Ennishi
, Hidenori Kage
, Masashi Kanai
, Keigo Komine
, Takafumi Koyama
, Takahiro Maeda
, Sachi Morita
, Daisuke Sakai
, Shinji Kohsaka
, Katsuya Tsuchihara
, Takayuki Yoshino

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The author wishes to update the original publication as follows: Under Results section of Abstract: The sentence starting with: “A total of…..” should read as: A total of 747 cases underwent CGP tests, 28 cases (3.7%) received genomically matched treatment, and 18 cases (2.4%) were referred for genetic counseling. In Results, under section: The performance of EPs at each core hospital: The sentence starting with: “Among the…” should read as: Among the 747 cases in core hospitals, 28 cases (3.7%, range 0–7.7%) received genomically matched treatments (Table 2); The sentence starting with: “Regarding the…” should read as: Regarding the germline findings, 18 of 747 cases (2.4%, range 0–15%) were referred for genetic counselling (Supplementary Table 2). In Table 4, the Recommended therapy for Site I should read as: Alpelisib, neratinib.

Original language	English
Pages (from-to)	1007
Number of pages	1
Journal	International Journal of Clinical Oncology
Volume	26
Issue number	5
DOIs	https://doi.org/10.1007/s10147-021-01897-w
Publication status	Published - 05-2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Surgery
Hematology
Oncology

Access to Document

10.1007/s10147-021-01897-w

Fingerprint

Dive into the research topics of 'Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1)'. Together they form a unique fingerprint.

Cite this

Sunami, K., Naito, Y., Aimono, E., Amano, T., Ennishi, D., Kage, H., Kanai, M., Komine, K., Koyama, T., Maeda, T., Morita, S., Sakai, D., Kohsaka, S., Tsuchihara, K., & Yoshino, T. (2021). Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1). International Journal of Clinical Oncology, 26(5), 1007. https://doi.org/10.1007/s10147-021-01897-w

@article{ad27985109bf417aaf5deed387f5013a,

title = "Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1)",

abstract = "The author wishes to update the original publication as follows: Under Results section of Abstract: The sentence starting with: “A total of…..” should read as: A total of 747 cases underwent CGP tests, 28 cases (3.7\%) received genomically matched treatment, and 18 cases (2.4\%) were referred for genetic counseling. In Results, under section: The performance of EPs at each core hospital: The sentence starting with: “Among the…” should read as: Among the 747 cases in core hospitals, 28 cases (3.7\%, range 0–7.7\%) received genomically matched treatments (Table 2); The sentence starting with: “Regarding the…” should read as: Regarding the germline findings, 18 of 747 cases (2.4\%, range 0–15\%) were referred for genetic counselling (Supplementary Table 2). In Table 4, the Recommended therapy for Site I should read as: Alpelisib, neratinib.",

author = "Kuniko Sunami and Yoichi Naito and Eriko Aimono and Toraji Amano and Daisuke Ennishi and Hidenori Kage and Masashi Kanai and Keigo Komine and Takafumi Koyama and Takahiro Maeda and Sachi Morita and Daisuke Sakai and Shinji Kohsaka and Katsuya Tsuchihara and Takayuki Yoshino",

note = "Publisher Copyright: {\textcopyright} 2021, Japan Society of Clinical Oncology.",

year = "2021",

month = may,

doi = "10.1007/s10147-021-01897-w",

language = "English",

volume = "26",

pages = "1007",

journal = "International Journal of Clinical Oncology",

issn = "1341-9625",

publisher = "Springer",

number = "5",

}

Sunami, K, Naito, Y, Aimono, E, Amano, T, Ennishi, D, Kage, H, Kanai, M, Komine, K, Koyama, T, Maeda, T, Morita, S, Sakai, D, Kohsaka, S, Tsuchihara, K & Yoshino, T 2021, 'Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1)', International Journal of Clinical Oncology, vol. 26, no. 5, pp. 1007. https://doi.org/10.1007/s10147-021-01897-w

Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1). / Sunami, Kuniko; Naito, Yoichi; Aimono, Eriko et al.
In: International Journal of Clinical Oncology, Vol. 26, No. 5, 05.2021, p. 1007.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction to

T2 - The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1)

AU - Sunami, Kuniko

AU - Naito, Yoichi

AU - Aimono, Eriko

AU - Amano, Toraji

AU - Ennishi, Daisuke

AU - Kage, Hidenori

AU - Kanai, Masashi

AU - Komine, Keigo

AU - Koyama, Takafumi

AU - Maeda, Takahiro

AU - Morita, Sachi

AU - Sakai, Daisuke

AU - Kohsaka, Shinji

AU - Tsuchihara, Katsuya

AU - Yoshino, Takayuki

PY - 2021/5

Y1 - 2021/5

N2 - The author wishes to update the original publication as follows: Under Results section of Abstract: The sentence starting with: “A total of…..” should read as: A total of 747 cases underwent CGP tests, 28 cases (3.7%) received genomically matched treatment, and 18 cases (2.4%) were referred for genetic counseling. In Results, under section: The performance of EPs at each core hospital: The sentence starting with: “Among the…” should read as: Among the 747 cases in core hospitals, 28 cases (3.7%, range 0–7.7%) received genomically matched treatments (Table 2); The sentence starting with: “Regarding the…” should read as: Regarding the germline findings, 18 of 747 cases (2.4%, range 0–15%) were referred for genetic counselling (Supplementary Table 2). In Table 4, the Recommended therapy for Site I should read as: Alpelisib, neratinib.

AB - The author wishes to update the original publication as follows: Under Results section of Abstract: The sentence starting with: “A total of…..” should read as: A total of 747 cases underwent CGP tests, 28 cases (3.7%) received genomically matched treatment, and 18 cases (2.4%) were referred for genetic counseling. In Results, under section: The performance of EPs at each core hospital: The sentence starting with: “Among the…” should read as: Among the 747 cases in core hospitals, 28 cases (3.7%, range 0–7.7%) received genomically matched treatments (Table 2); The sentence starting with: “Regarding the…” should read as: Regarding the germline findings, 18 of 747 cases (2.4%, range 0–15%) were referred for genetic counselling (Supplementary Table 2). In Table 4, the Recommended therapy for Site I should read as: Alpelisib, neratinib.

UR - https://www.scopus.com/pages/publications/85103392542

UR - https://www.scopus.com/pages/publications/85103392542#tab=citedBy

U2 - 10.1007/s10147-021-01897-w

DO - 10.1007/s10147-021-01897-w

M3 - Comment/debate

C2 - 33786712

AN - SCOPUS:85103392542

SN - 1341-9625

VL - 26

SP - 1007

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

IS - 5

ER -

Sunami K, Naito Y, Aimono E, Amano T, Ennishi D, Kage H et al. Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1). International Journal of Clinical Oncology. 2021 May;26(5):1007. doi: 10.1007/s10147-021-01897-w

Correction to: The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan (International Journal of Clinical Oncology, (2021), 26, 3, (443-449), 10.1007/s10147-020-01844-1)

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this